TriangleNCT05070247 · OUTCOME
Dose Expansion: Overall Survival (OS)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Up to approximately 32.8 months
What was measured
OS is defined as the time from the date of first dose administration to the date of death.
Analysis population: Due to early study termination, Dose Expansion Phase was not initiated and hence, no data was collected for this outcome measure.
Groups in this outcome
Dose Expansion: TAK-500
Participants were planned to receive TAK-500 at recommended doses based on dose escalation cohorts. No participants were enrolled in the expansion phase due to early termination of the study before initiating this phase.
| Group | Source count |
|---|---|
| Dose Expansion: TAK-500 | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- OS is defined as the time from the date of first dose administration to the date of death.
- groups
- description
- Participants were planned to receive TAK-500 at recommended doses based on dose escalation cohorts. No participants were enrolled in the expansion phase due to early termination of the study before initiating this phase.
- id
- OG000
- title
- Dose Expansion: TAK-500
- population Description
- Due to early study termination, Dose Expansion Phase was not initiated and hence, no data was collected for this outcome measure.
- reporting Status
- POSTED
- time Frame
- Up to approximately 32.8 months
- title
- Dose Expansion: Overall Survival (OS)
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice